Sigma Healthcare Limited (S5YA) - Net Assets
Based on the latest financial reports, Sigma Healthcare Limited (S5YA) has net assets worth €839.28 Million EUR (≈ $981.20 Million USD) as of January 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€1.83 Billion ≈ $2.14 Billion USD) and total liabilities (€991.29 Million ≈ $1.16 Billion USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check strategic asset allocation of Sigma Healthcare Limited to assess the company's strategic physical and investment asset allocation.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €839.28 Million |
| % of Total Assets | 45.85% |
| Annual Growth Rate | 5.7% |
| 5-Year Change | 56.9% |
| 10-Year Change | N/A |
| Growth Volatility | 28.64 |
Sigma Healthcare Limited - Net Assets Trend (2017–2025)
This chart illustrates how Sigma Healthcare Limited's net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see S5YA market cap overview.
Annual Net Assets for Sigma Healthcare Limited (2017–2025)
The table below shows the annual net assets of Sigma Healthcare Limited from 2017 to 2025. Also explore net asset growth rate of Sigma Healthcare Limited to track the company's year-over-year net asset growth rate.
| Year | Net Assets | Change |
|---|---|---|
| 2025-01-31 | €839.28 Million ≈ $981.20 Million |
-3.82% |
| 2024-01-31 | €872.61 Million ≈ $1.02 Billion |
+82.64% |
| 2023-01-31 | €477.77 Million ≈ $558.56 Million |
-2.25% |
| 2022-01-31 | €488.78 Million ≈ $571.43 Million |
-8.62% |
| 2021-01-31 | €534.90 Million ≈ $625.36 Million |
+12.20% |
| 2020-01-31 | €476.74 Million ≈ $557.36 Million |
-7.30% |
| 2019-01-31 | €514.28 Million ≈ $601.25 Million |
-0.19% |
| 2018-01-31 | €515.26 Million ≈ $602.39 Million |
-4.33% |
| 2017-01-31 | €538.59 Million ≈ $629.66 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Sigma Healthcare Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 9883600000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (January 2025)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | €798.11 Million | % |
| Total Equity | €-1.42 Million | 100.00% |
Sigma Healthcare Limited Competitors by Market Cap
The table below lists competitors of Sigma Healthcare Limited ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Kyocera Corporation
F:KYRA
|
$19.76 Billion |
|
Huatai Securities Co Ltd
SHG:601688
|
$19.76 Billion |
|
Yihai Kerry Arawana Holdings Co Ltd
SHE:300999
|
$19.76 Billion |
|
InterGlobe Aviation Limited
NSE:INDIGO
|
$19.79 Billion |
|
Lundin Mining Corporation
TO:LUN
|
$19.72 Billion |
|
Industrias Peñoles S.A.B. de C.V
MX:PE&OLES
|
$19.71 Billion |
|
Bouygues SA
PA:EN
|
$19.69 Billion |
|
General Mills Inc
NYSE:GIS
|
$19.65 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Sigma Healthcare Limited's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 870,770,000 to -1,418,000, a change of -872,188,000 (-100.2%).
- Net income of 529,914,000 contributed positively to equity growth.
- Dividend payments of 1,186,036,000 reduced retained earnings.
- Share repurchases of 6,416,000 reduced equity.
- New share issuances of 7,182,000 increased equity.
- Other factors decreased equity by 216,832,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €529.91 Million | +37370.52% |
| Dividends Paid | €1.19 Billion | -83641.47% |
| Share Repurchases | €6.42 Million | -452.47% |
| Share Issuances | €7.18 Million | +506.49% |
| Other Changes | €-216.83 Million | -15291.4% |
| Total Change | €- | -100.16% |
Book Value vs Market Value Analysis
This analysis compares Sigma Healthcare Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2018-01-31 | €0.48 | €1.57 | x |
| 2019-01-31 | €0.48 | €1.57 | x |
| 2020-01-31 | €0.45 | €1.57 | x |
| 2021-01-31 | €0.50 | €1.57 | x |
| 2022-01-31 | €0.46 | €1.57 | x |
| 2023-01-31 | €0.45 | €1.57 | x |
| 2024-01-31 | €0.53 | €1.57 | x |
| 2025-01-31 | €0.00 | €1.57 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Sigma Healthcare Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 8.83%
- • Asset Turnover: 3.28x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is below the historical average (3.97%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2017 | 9.91% | 1.20% | 3.95x | 2.08x | €-492.30K |
| 2018 | 10.73% | 1.33% | 3.16x | 2.55x | €3.75 Million |
| 2019 | 7.12% | 0.91% | 2.90x | 2.70x | €-14.81 Million |
| 2020 | -2.59% | -0.38% | 2.68x | 2.55x | €-59.93 Million |
| 2021 | 11.19% | 1.76% | 2.82x | 2.26x | €6.34 Million |
| 2022 | -1.49% | -0.21% | 2.76x | 2.56x | €-55.96 Million |
| 2023 | 0.38% | 0.05% | 3.17x | 2.47x | €-45.78 Million |
| 2024 | 0.52% | 0.13% | 2.45x | 1.58x | €-82.57 Million |
| 2025 | 0.00% | 8.83% | 3.28x | 0.00x | €530.06 Million |
Industry Comparison
This section compares Sigma Healthcare Limited's net assets metrics with peer companies in the Medical Distribution industry.
Industry Context
- Industry: Medical Distribution
- Average net assets among peers: $46,001,318
- Average return on equity (ROE) among peers: -9.27%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Sigma Healthcare Limited (S5YA) | €839.28 Million | 9.91% | 1.18x | $19.74 Billion |
| AKSO HEALTH GR. (SPADR)/3 (8HX) | $199.15 Million | -67.78% | 0.08x | $1.60 Billion |
| EDAP TMS S.A (EDA) | $26.25 Million | -7.45% | 1.10x | $132.10 Million |
| Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (GU5) | $7.02 Billion | 13.96% | 0.74x | $367.63 Million |
| CLOUDR GROUP LTD. (H3L) | $-7.16 Billion | 0.00% | 0.00x | $31.33 Million |
| Medios AG (ILM1) | $7.38 Million | 0.00% | -0.40x | $289.23 Million |
| M1 Kliniken AG (M12) | $30.26 Million | 16.55% | 0.06x | $300.08 Million |
| Paragon Care Limited (PXS) | $192.32 Million | -7.48% | 1.00x | $130.61 Million |
| TELES Informationstechnologien AG (TLIK) | $55.51 Million | 20.17% | 0.56x | $947.38K |
| COSMOS HEALTH NEW DL-01 (V67A) | $36.04 Million | -51.45% | 0.83x | $14.37 Million |
About Sigma Healthcare Limited
Sigma Healthcare Limited operates as a retail pharmacy franchisor and pharmaceutical wholesale and distributor to community pharmacies primarily in Australia. It offers support services to a network of franchised retail pharmacies; third and fourth party logistics services to pharmaceutical manufacturers and other supplier partners; and health services. The company operates stores under the Chemi… Read more